Jody Baron and Gabi Fragiadakis discover why some people with chronic Hepatitis B are cured after they're taken off of ...

Fifteen years ago, doctors in Europe noticed a remarkable thing happening in people with chronic hepatitis B infections. When ...

FDA regulatory momentum includes priority review and breakthrough therapy designation for a potential first-in-class CHB ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A Durham company is making ...

University of California, San Francisco researchers have identified a crucial immune mechanism involving CD4+ T cells that ...

May 11 (Reuters) - GSK said on Monday it had entered into a strategic collaboration with Hong Kong-listed Sino ...

—In a global study of 614 adults with chronic hepatitis B (CHB), treatment compliance was affected by obstacles such as physical functioning and healthcare service accessibility, making clear the need ...

Hepatitis B virus (HBV) causes hepatitis B. Worldwide, hepatitis B is thought to be the second deadliest infection; it's estimated that about five percent of the global population have the disease.

Liver specialist Maurizio Bonacini is in the race for a cure for hepatitis B, one of the world’s most widespread diseases and a top cause of liver cancer around the globe. “It’s the last frontier,” ...

A large percentage of US patients eligible for HBV treatment remain untreated, despite effective therapies reducing adverse outcomes like cirrhosis and hepatocellular carcinoma. Disparities in HBV ...

Assembly Biosciences (NASDAQ:ASMB) Chief Medical Officer Anuj Gaggar outlined the company's virology strategy and upcoming ...

Millions of Americans live with chronic hepatitis and may not know it, because it can take years to become symptomatic. The most common types of the virus, hepatitis B and C, can lead to liver failure ...